PACE is a partnership focused on addressing the global threat of antimicrobial resistance (AMR) through funding and supporting early-stage antimicrobial drug and diagnostics projects. It has a £30 million initiative to develop solutions related to patient health.
PACE is operated by Lifearc and is a Active company incorporated on 18 March 1992 with the registered office located in London, Greater London. Lifearc was registered 33 years ago.